Literature DB >> 10497984

Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis.

K Ahmed1, K A Al-Matrouk, G Martinez, K Oishi, V O Rotimi, T Nagatake.   

Abstract

Brucellosis is a zoonotic disease that often becomes chronic with a high rate of recurrence. To understand the cytokines induced during this infection we determined the levels of interleukin (IL)-1beta, IL-2, IL-4, IL-8, IL-12, tumor necrosis factor-of (TNF-alpha) and interferon-gamma (IFN-gamma) in serum of patients with brucellosis and compared with those without brucellosis and controls. Control sera were taken from healthy persons residing in an area that was not endemic for brucellosis. The levels of IL-1, IL-2, IL-4, and TNF-alpha were not detectable in all the sera from patients. There was no difference in the level of IL-8 in patients with brucellosis and those without this disease. However, IL-8 was significantly higher in these two groups of patients compared with the controls. Significantly higher levels of IL-12 and IFN-alpha were found in the serum of patients with brucellosis compared with patients without brucellosis and controls. These data indicate that there is induction of Thl type cytokines during human brucellosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497984     DOI: 10.4269/ajtmh.1999.61.425

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Authors:  Jerod A Skyberg; Theresa Thornburg; Irina Kochetkova; William Layton; Gayle Callis; MaryClare F Rollins; Carol Riccardi; Todd Becker; Sarah Golden; David W Pascual
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

2.  Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function.

Authors:  Manuel Rodríguez-Zapata; Marlene J Matías; Alfredo Prieto; Marco A Jonde; Jorge Monserrat; Lorenzo Sánchez; Eduardo Reyes; Antonio De la Hera; Melchor Alvarez-Mon
Journal:  Infect Immun       Date:  2010-04-19       Impact factor: 3.441

3.  CD80/CD28 co-stimulation in human brucellosis.

Authors:  P Skendros; P Boura; F Kamaria; M Raptopoulou-Gigi
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

Review 4.  The Role of Neutrophils in Brucellosis.

Authors:  Edgardo Moreno; Elías Barquero-Calvo
Journal:  Microbiol Mol Biol Rev       Date:  2020-10-14       Impact factor: 11.056

Review 5.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

Review 6.  Laboratory animal models for brucellosis research.

Authors:  Teane M A Silva; Erica A Costa; Tatiane A Paixão; Renée M Tsolis; Renato L Santos
Journal:  J Biomed Biotechnol       Date:  2011-02-20

7.  Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs.

Authors:  Panagiotis Skendros; Alexandros Sarantopoulos; Konstantinos Tselios; Panagiota Boura
Journal:  Clin Dev Immunol       Date:  2009-01-25

8.  Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosis.

Authors:  Kristyn E Feldman; Paul M Loriaux; Mayuko Saito; Iskra Tuero; Homarh Villaverde; Tenaya Siva; Eduardo Gotuzzo; Robert H Gilman; Alexander Hoffmann; Joseph M Vinetz
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05

Review 9.  The meteorology of cytokine storms, and the clinical usefulness of this knowledge.

Authors:  Ian A Clark; Bryce Vissel
Journal:  Semin Immunopathol       Date:  2017-04-27       Impact factor: 11.759

10.  Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo.

Authors:  Yun Zhao; Sean Hanniffy; Vilma Arce-Gorvel; Raquel Conde-Alvarez; SangKon Oh; Ignacio Moriyón; Sylvie Mémet; Jean-Pierre Gorvel
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.